Quarterly report pursuant to Section 13 or 15(d)

Composition of Certain Financial Statement Captions - Changes in Goodwill (Details)

v3.21.2
Composition of Certain Financial Statement Captions - Changes in Goodwill (Details) - USD ($)
$ in Thousands
6 Months Ended
Jun. 30, 2021
Jan. 01, 2021
Dec. 31, 2020
Goodwill [Roll Forward]      
Goodwill, beginning balance $ 677,360 $ 718,625 $ 680,602
Cumulative impairment at January 1   (38,023)  
Goodwill impairment 0    
Foreign exchange and other (3,242)    
Goodwill, ending balance 677,360 718,625 $ 680,602
BioReference      
Goodwill [Roll Forward]      
Goodwill, beginning balance 434,800    
Goodwill, ending balance 434,800    
Pharmaceutical | CURNA      
Goodwill [Roll Forward]      
Goodwill, beginning balance 0 4,827  
Cumulative impairment at January 1   (4,827)  
Goodwill impairment 0    
Foreign exchange and other 0    
Goodwill, ending balance 0 4,827  
Pharmaceutical | Rayaldee      
Goodwill [Roll Forward]      
Goodwill, beginning balance 90,543 93,418  
Cumulative impairment at January 1   0  
Goodwill impairment 0    
Foreign exchange and other (2,875)    
Goodwill, ending balance 90,543 93,418  
Pharmaceutical | FineTech      
Goodwill [Roll Forward]      
Goodwill, beginning balance 0 11,698  
Cumulative impairment at January 1   (11,698)  
Goodwill impairment 0    
Foreign exchange and other 0    
Goodwill, ending balance 0 11,698  
Pharmaceutical | OPKO Biologics      
Goodwill [Roll Forward]      
Goodwill, beginning balance 139,784 139,784  
Cumulative impairment at January 1   0  
Goodwill impairment 0    
Foreign exchange and other 0    
Goodwill, ending balance 139,784 139,784  
Pharmaceutical | OPKO Chile      
Goodwill [Roll Forward]      
Goodwill, beginning balance 4,392 4,505  
Cumulative impairment at January 1   0  
Goodwill impairment 0    
Foreign exchange and other (113)    
Goodwill, ending balance 4,392 4,505  
Pharmaceutical | OPKO Health Europe      
Goodwill [Roll Forward]      
Goodwill, beginning balance 7,832 8,086  
Cumulative impairment at January 1   0  
Goodwill impairment 0    
Foreign exchange and other (254)    
Goodwill, ending balance 7,832 8,086  
Pharmaceutical | OPKO Mexico      
Goodwill [Roll Forward]      
Goodwill, beginning balance 0 100  
Cumulative impairment at January 1   (100)  
Goodwill impairment 0    
Foreign exchange and other 0    
Goodwill, ending balance 0 100  
Pharmaceutical | Transition Therapeutics      
Goodwill [Roll Forward]      
Goodwill, beginning balance 0 3,421  
Cumulative impairment at January 1   (3,421)  
Goodwill impairment 0    
Foreign exchange and other 0    
Goodwill, ending balance 0 3,421  
Diagnostics | BioReference      
Goodwill [Roll Forward]      
Goodwill, beginning balance 434,809 434,809  
Cumulative impairment at January 1   0  
Goodwill impairment 0    
Foreign exchange and other 0    
Goodwill, ending balance 434,809 434,809  
Diagnostics | OPKO Diagnostics      
Goodwill [Roll Forward]      
Goodwill, beginning balance 0 17,977  
Cumulative impairment at January 1   (17,977)  
Goodwill impairment 0    
Foreign exchange and other 0    
Goodwill, ending balance $ 0 $ 17,977